百济神州一季度亏损收窄,昊海生科实控人被立案,“减肥神药”司美格鲁肽Q1爆卖近80亿美元,德展健康涉合同纠纷诉讼

谈医说药
May 07

诺和诺德:2025年一季度业绩实现净销售额780.87亿丹麦克朗,约110.1亿美元(按今年第一季度平均汇率计算)。其中,中国市场实现收入56.22亿丹麦克朗(约合7.92亿美元),同比增长9%,占总收入的比重达到7.19%。美国市场实现营收443.16亿丹麦克朗(约合62.49亿美元),同比增长53%。明星产品司美格鲁肽实现收入557.76亿丹麦克朗(约78.64亿美元),占诺和诺德总营收的七成...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10